about
Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis.Ten years of Chagas disease research: Looking back to achievements, looking ahead to challengesSystematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas DiseaseImproving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participationTrypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruziRepurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors.Molecular diagnostics for Chagas disease: up to date and novel methodologies.Mutagenic and Cytotoxicity LQB 123 Profile: Safety and Tripanocidal Effect of a Phenyl-t-Butylnitrone Derivative.PLOS Neglected Tropical Diseases: Ten years of progress in neglected tropical disease control and elimination … More or less.Nonhuman Primates and Translational Research-Cardiovascular Disease.Modulation of host central carbon metabolism and in situ glucose uptake by intracellular Trypanosoma cruzi amastigotes.Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.In vitro, in silico and in vivo analysis of novel aromatic amidines against Trypanosoma cruzi.Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.Host triacylglycerols shape the lipidome of intracellular trypanosomes and modulate their growth.Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi.What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.Chagas Cardiomyopathy Presenting as Symptomatic Bradycardia: An Underappreciated Emerging Public Health Problem in the United States.Congenitally transmitted Chagas disease in Canada: a family cluster.Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.Chagas Disease-induced Sudden Cardiac Arrest.Efficacy of sertraline against : an in vitro and in silico study
P2860
Q33563137-2BC0BBC5-C88F-4AF0-B950-78A69AC52911Q33584473-89BB73EE-AD6F-4EBA-BB52-29217ABEC034Q36109819-7C68506C-69BA-4C14-89E8-A257F77A9B83Q36278397-06733F1F-9A07-4992-AE32-D01105EAECBBQ36312076-E016C662-C9EB-4A3A-8839-D8DA5B254349Q38972808-7F5181BB-46CF-485F-981A-65A1776EF9D8Q39180209-660614FA-1B2D-48D0-A5ED-58DB29D9E6BAQ40057259-4D9D7496-1B48-4412-9F33-81FDE1F008F2Q40184873-3934D6DD-B049-4215-94FD-BC55C2DD2E1CQ40288847-FB145C60-6108-4F5D-B3C5-C2D96A6EA275Q42360808-A337D697-2142-4BF8-935E-33D81177CDBFQ46292627-20163B41-262F-457D-97B7-6DF8B38A2927Q47120125-2F09F2B8-EBB0-4429-B68B-8426BA4A1A3DQ47136773-544309B9-6320-41FA-BCE5-9D85F6B95F32Q47371103-2870DA40-C959-4897-A0E8-6EF766A4FA8DQ47557112-134FC808-5B2D-43AE-A982-52BA03658E2EQ47761949-4001DEB9-638B-4ECC-BD96-0FBBE3B820D7Q48149936-1446A00F-BB06-4392-A1FB-6997A73404C9Q48230391-593D2AAA-B3E1-4DF3-AE86-118DC216E302Q48235481-93B3F10F-FD16-4E3C-980D-CF7034E1AC0CQ48530669-CFD0B91C-96AE-4394-8F69-939FF812C87FQ49744481-9F419250-D325-4A60-B572-34197386DF65Q50082572-44F09B39-BD3C-463F-A7D3-855B9DA410B9Q52619024-61F51EF3-51F1-43DA-AE77-6E544EA20DFCQ55083098-71271A14-E7C2-4572-BC81-ACC16709BB30Q59132384-83008C32-1295-4F79-90E0-DE7267BE43AC
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The BENEFIT Trial: Where Do We Go from Here?
@en
The BENEFIT Trial: Where Do We Go from Here?
@nl
type
label
The BENEFIT Trial: Where Do We Go from Here?
@en
The BENEFIT Trial: Where Do We Go from Here?
@nl
prefLabel
The BENEFIT Trial: Where Do We Go from Here?
@en
The BENEFIT Trial: Where Do We Go from Here?
@nl
P2093
P2860
P50
P1476
The BENEFIT Trial: Where Do We Go from Here?
@en
P2093
Ana Pereiro
Bernard Pecoul
Carolina Batista
Eric Stobbaerts
Isabella Ribeiro
Rafael Vilasanjuan
Silvia Gold
Silvia Moriana
P2860
P304
P356
10.1371/JOURNAL.PNTD.0004343
P407
P577
2016-02-25T00:00:00Z